We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




CVD Risk Unrelated to Weight in Metabolically Healthy Women

By HospiMedica International staff writers
Posted on 11 Sep 2013
Metabolically healthy women have the same cardiovascular disease (CVD) risk regardless of their body mass index (BMI), according to a new study.

Researchers at Gentofte Hospital (Hellerup, Denmark) used the Danish national health databases to follow 261,489 women (mean age 31 years) who had given birth during 2004-2009, with no prior history of CVD disease. More...
The women were divided into four categories according to their pre-pregnancy body mass index (BMI) and presence of metabolic disorders, and were followed for five years after childbirth. Metabolic disorders were defined by claimed prescription data, and discharge diagnoses and data on cause of death were used to determine if the women had a heart attack, a stroke, or died; pregnancy-associated metabolic disorders were defined using diagnosis codes.

The results showed that being overweight but metabolically healthy is not associated with an excess CVD risk in comparison with normal weight healthy women; metabolically unhealthy, overweight women, however, had an almost 7-fold increased risk of heart attack and a 4-fold increased risk of stroke. The authors claim, however, that the results suggest that development of metabolic disorders, for which obesity is a major determinant, is associated with a marked increase in CVD, even in the short term. The study was presented at the 2013 European Society of Cardiology (ESC) Congress, held during September 2013 in Amsterdam (The Netherlands).

“Obesity might not be all bad if the overweight woman has not developed any hypertensive disorders, disorders in glucose-metabolism or elevated cholesterol levels,” said study presenter and coauthor Michelle Schmiegelow, MD. “But because obesity markedly increases the risk of developing these metabolic disorders, these women most likely have a window of opportunity to lose weight and change their prognosis."

Metabolic disorders include hypertensive disorders, such as hypertension, gestational hypertension, or pre-eclampsia; disorders in glucose-metabolism, such as diabetes and gestational diabetes; and elevated cholesterol levels (dyslipidemia).

Related Links:

Gentofte Hospital




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.